mRNA |
BRD-A02303741:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
1e-05 |
mRNA |
EX-527 |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
4e-05 |
mRNA |
Lisitinib |
GDSC1000 |
pan-cancer |
AAC |
0.13 |
0.0001 |
mRNA |
FR-180204 |
GDSC1000 |
pan-cancer |
AAC |
0.13 |
0.0002 |
mRNA |
vorinostat:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
0.0003 |
mRNA |
BRD-K84807411 |
CTRPv2 |
pan-cancer |
AAC |
0.26 |
0.0004 |
mRNA |
JQ-1:vorinostat (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.0004 |
mRNA |
UNC0638:navitoclax (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.0008 |
mRNA |
thalidomide |
CTRPv2 |
pan-cancer |
AAC |
0.18 |
0.001 |
mRNA |
AZ628 |
GDSC1000 |
pan-cancer |
AAC |
0.16 |
0.002 |